Insulin reduces LPS-induced lethality and lung injury in rats

Pulm Pharmacol Ther. 2012 Dec;25(6):472-7. doi: 10.1016/j.pupt.2012.09.002. Epub 2012 Sep 13.

Abstract

Insulin is a main glucose homeostatic hormone in the body. Previous reports showed that insulin also exerted anti-inflammatory actions and attenuated systemic inflammatory response. Here, we observed the effects and the underlying mechanisms of insulin on lipopolysaccharide (LPS)-induced acute lung injury (ALI). As revealed by survival study, insulin reduced mortality of rats and prolonged their survival time. Meanwhile, insulin significantly reduced the levels of inflammatory cytokines including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and high mobility group box 1 (HMGB1) in bronchoalveolar lavage fluid (BALF). Besides, insulin markedly inhibited the expression of toll-like receptor 2 (TLR2), toll-like receptor 4 (TLR4) and nuclear factor-κB (NF-κB). Taken together, these data provided information that insulin attenuated LPS-induced ALI may attribute partly to the inhibition of the production of cytokines, and the expression of TLR2, TLR4 and NF-κB.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Lung Injury / drug therapy*
  • Acute Lung Injury / pathology
  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Bronchoalveolar Lavage Fluid
  • Cytokines / metabolism
  • Gene Expression Regulation / drug effects
  • Inflammation / drug therapy*
  • Inflammation / pathology
  • Insulin / pharmacology*
  • Lipopolysaccharides / toxicity
  • Male
  • NF-kappa B / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Survival Rate
  • Toll-Like Receptor 2 / genetics
  • Toll-Like Receptor 4 / genetics

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Insulin
  • Lipopolysaccharides
  • NF-kappa B
  • Tlr2 protein, rat
  • Tlr4 protein, rat
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4